Director at CONMED (NYSE: CNMD) receives 5,772 RSUs under 2025 incentive plan

Rhea-AI Filing Summary

CONMED Corp director Kim Kelderman received a grant of 5,772 restricted stock units (RSUs) as equity compensation. Each RSU represents a contingent right to receive one share of CONMED common stock under the company’s 2025 Long-Term Incentive Plan.

The RSUs generally vest 100% after one year, aligning Kelderman’s compensation with shareholder interests over that period. Following this award, Kelderman holds 5,772 RSUs directly, which may convert into the same number of common shares if the vesting conditions are satisfied.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kelderman Kim

Role null

Type	Security	Shares	Price	Value
Grant/Award	RSUs (Restricted Stock Units)	5,772	$0.00	--

Holdings After Transaction: RSUs (Restricted Stock Units) — 5,772 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 5,772 units RSU-to-share ratio: 1 RSU : 1 share Vesting schedule: 100% after one year +3 more

6 metrics

RSUs granted 5,772 units Equity award to director Kim Kelderman

RSU-to-share ratio 1 RSU : 1 share Each unit delivers one common share if vested

Vesting schedule 100% after one year General vesting period for this RSU award

Exercise price $0.00 per unit No purchase price for RSU grant

Holdings after award 5,772 RSUs Total RSUs held directly following transaction

Plan name 2025 Long-Term Incentive Plan Governs terms and conditions of RSU grant

Key Terms

Restricted Stock Units, contingent right, Long-Term Incentive Plan, vest

4 terms

Restricted Stock Units financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"represents a contingent right to receive one share of common stock"

Long-Term Incentive Plan financial

"subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan"

A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.

vest financial

"with the RSUs generally vesting 100% after a one year period"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kelderman Kim

(Last) (First) (Middle)

C/O CONMED CORPORATION

11311 CONCEPT BOULEVARD

(Street)

LARGO FLORIDA 33773

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
RSUs (Restricted Stock Units)	$0	06/01/2026		A		5,772		06/01/2027(1)	06/01/2036	Common Stock	5,772	$0	5,772	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.

	/s/ Thomas Fistek for Kim Kelderman by Power of Attorney	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CONMED Corp (CNMD) report for Kim Kelderman?

CONMED reported that director Kim Kelderman received a grant of 5,772 RSUs. These restricted stock units are part of equity compensation and may convert into an equal number of common shares if they vest under the company’s 2025 Long-Term Incentive Plan.

How many RSUs did Kim Kelderman receive from CONMED Corp (CNMD)?

Kim Kelderman received 5,772 restricted stock units. Each RSU represents a contingent right to one CONMED common share, subject to vesting conditions set out in the company’s 2025 Long-Term Incentive Plan and a one-year vesting schedule.

When do Kim Kelderman’s CONMED (CNMD) RSUs vest?

The RSUs generally vest 100% after a one-year period from the grant date. Once vested, each restricted stock unit can deliver one share of CONMED common stock, provided all plan terms and conditions are satisfied under the 2025 Long-Term Incentive Plan.

What does each RSU granted to Kim Kelderman by CONMED (CNMD) represent?

Each RSU represents a contingent right to receive one share of CONMED common stock. The units carry no purchase price, are subject to the 2025 Long-Term Incentive Plan, and must vest, generally after one year, before shares are actually delivered.

Is Kim Kelderman’s CONMED (CNMD) RSU grant an open-market stock purchase?

No, the Form 4 shows a grant of 5,772 RSUs as compensation, not an open-market purchase. The award has a zero transaction price and is classified as a grant or award acquisition under the company’s 2025 Long-Term Incentive Plan.

How many CONMED (CNMD) RSUs does Kim Kelderman hold after this transaction?

After this transaction, Kelderman holds 5,772 RSUs directly. These restricted stock units may convert into 5,772 shares of CONMED common stock if they vest according to the one-year schedule and the conditions of the 2025 Long-Term Incentive Plan.